FAM120A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.280800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.435200E-01
Normal-vs-Stage2
4.761200E-01
Normal-vs-Stage3
1.471210E-01
Normal-vs-Stage4
2.861000E-01
Stage1-vs-Stage2
7.140600E-01
Stage1-vs-Stage3
1.149170E-01
Stage1-vs-Stage4
3.706600E-01
Stage2-vs-Stage3
3.860000E-02
Stage2-vs-Stage4
4.039400E-01
Stage3-vs-Stage4
1.743990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.676200E-01
Normal-vs-AfricanAmerican
6.267800E-01
Normal-vs-Asian
2.706200E-01
Caucasian-vs-AfricanAmerican
9.683800E-01
Caucasian-vs-Asian
2.841200E-01
AfricanAmerican-vs-Asian
4.926400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.866200E-01
Normal-vs-Female
5.887000E-01
Male-vs-Female
6.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.546600E-01
Normal-vs-Age(41-60Yrs)
3.290000E-01
Normal-vs-Age(61-80Yrs)
6.227400E-01
Normal-vs-Age(81-100Yrs)
5.050200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.019440E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.763800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.593430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.746380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.049800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.753400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.547800E-01
Normal-vs-Daily Drinker
7.057800E-01
Normal-vs-Weekly Drinker
7.894600E-01
Normal-vs-Occasional Drinker
3.538400E-01
Normal-vs-Social Drinker
2.695000E-01
Non Drinker-vs-Daily Drinker
6.246200E-01
Non Drinker-vs-Weekly Drinker
8.777400E-01
Non Drinker-vs-Occasional Drinker
6.148100E-02
Non Drinker-vs-Social Drinker
2.751400E-01
Daily Drinker-vs-Weekly Drinker
7.928200E-01
Daily Drinker-vs-Occasional Drinker
1.997440E-01
Daily Drinker-vs-Social Drinker
7.030600E-01
Weekly Drinker-vs-Occasional Drinker
1.671440E-01
Weekly Drinker-vs-Social Drinker
4.962000E-01
Occasional Drinker-vs-Social Drinker
2.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.272300E-02
Normal-vs-Grade 2
1.105550E-02
Normal-vs-Grade 3
1.919040E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.778100E-03
Grade 1-vs-Grade 3
3.271700E-02
Grade 1-vs-Grade 4
3.272300E-02
Grade 2-vs-Grade 3
2.721800E-01
Grade 2-vs-Grade 4
1.105550E-02
Grade 3-vs-Grade 4
1.919040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.940200E-01
Normal-vs-NonDiabetic
5.003000E-01
Diabetic-vs-NonDiabetic
2.482600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.786600E-01
Normal-vs-NoPancreatitis
5.635200E-01
Pancreatitis-vs-NoPancreatitis
9.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.020400E-01
Normal-vs-N1
5.162800E-01
N0-vs-N1
7.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.137100E-03
Normal-vs-TP53-NonMutant
2.073800E-01
TP53-Mutant-vs-TP53-NonMutant
5.237500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
